Seventeen years' experience with mineral oil adjuvant influenza virus vaccines.
D000276:Adjuvants, Immunologic / Q000009:adverse effects / Q000627:therapeutic use; D000818:Animals; D000937:Antigen-Antibody Reactions; D044383:Black People; D002273:Carcinogens; D002675:Child, Preschool; D003560:Cysts / Q000139:chemically induced; D006168:Guinea Pigs; D000882:Haplorhini / Q000276:immunology; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000139:chemically induced; D007252:Influenza Vaccines / Q000627:therapeutic use; D007279:Injections, Subcutaneous; D051379:Mice; D008899:Mineral Oil / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use; D010406:Penicillins / Q000009:adverse effects; D014611:Vaccination / Q000009:adverse effects
D000276:Adjuvants, Immunologic; D002273:Carcinogens; D007252:Influenza Vaccines; D010406:Penicillins; D008899:Mineral Oil